PALLONI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1381
EU - Europa 975
AS - Asia 403
AF - Africa 64
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2834
Nazione #
US - Stati Uniti d'America 1369
GB - Regno Unito 280
IT - Italia 234
SE - Svezia 222
VN - Vietnam 180
CN - Cina 111
DE - Germania 94
IN - India 81
TG - Togo 41
FR - Francia 35
RU - Federazione Russa 32
ZA - Sudafrica 20
EE - Estonia 18
GR - Grecia 18
CA - Canada 12
UA - Ucraina 11
TR - Turchia 9
KR - Corea 8
CH - Svizzera 5
CL - Cile 4
BE - Belgio 3
IR - Iran 3
NL - Olanda 3
PL - Polonia 3
PT - Portogallo 3
RO - Romania 3
SC - Seychelles 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BR - Brasile 2
FI - Finlandia 2
HU - Ungheria 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
IQ - Iraq 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2834
Città #
Southend 268
Fairfield 224
Dong Ket 126
Houston 122
Chandler 112
Princeton 102
Wilmington 91
Ashburn 90
Woodbridge 87
Seattle 82
Cambridge 65
Ann Arbor 57
Bologna 43
Lomé 41
Berlin 32
Redmond 32
Nanjing 27
Westminster 25
Beijing 19
Frankfurt am Main 18
San Diego 17
Padova 14
Medford 13
Des Moines 10
Ravenna 10
Jinan 9
Shenyang 8
Istanbul 7
Torino 7
Toronto 7
Hebei 6
Nanchang 6
Saint Petersburg 6
Dearborn 5
Haikou 5
Hefei 5
Redwood City 5
Rome 5
Zhengzhou 5
Athens 4
Fremont 4
Jiaxing 4
Milan 4
Napoli 4
Norwalk 4
Changsha 3
Leawood 3
Mahé 3
Ottawa 3
Plauen 3
San Mateo 3
Tianjin 3
Ardabil 2
Brussels 2
Chicago 2
Como 2
Den Haag 2
Falls Church 2
Hangzhou 2
Helsinki 2
Lausanne 2
Monmouth Junction 2
North York 2
Siena 2
São Paulo 2
Tokyo 2
Tulsa 2
Warsaw 2
Alexandria 1
Altedo 1
Andover 1
Auckland 1
Basra 1
Beograd 1
Biella 1
Bra 1
Bratislava 1
Brescia 1
Budapest 1
Buffalo 1
Bussolengo 1
Büdelsdorf 1
Casalecchio Di Reno 1
Casalmaggiore 1
Castel Maggiore 1
Castelnuovo Rangone 1
Catania 1
Cesena 1
Chisinau 1
Civitanova Marche 1
Cortona 1
Costa Mesa 1
Dhaka 1
Eden Prairie 1
Fayetteville 1
Feltre 1
Fontenay-sous-bois 1
Forlì 1
Frankfurt Am Main 1
Gardone Val Trompia 1
Totale 1922
Nome #
Adjuvant treatment in biliary tract cancer 162
Follow-up del cancro del pancreas esocrino 143
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 130
D32Left versus right side primary tumor: the correlation with clinical outcome of patients with resected stage II and III colorectal cancer 127
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 126
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 113
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 111
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 109
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 109
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 107
Bone metastases in biliary cancers: A multicenter retrospective survey 102
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 97
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 85
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 83
In Reply 81
State of the art biological therapies in pancreatic cancer 78
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 77
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 77
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements 74
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 72
Radiotherapy or chemoradiation in unresectable biliary cancer: A retrospective study 72
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 72
INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS 69
Searching for novel multimodal treatments in oligometastatic pancreatic cancer 65
Chemotherapy in Patients with Advanced Cholangiocarcinoma 59
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 55
Should we incorporate ablative radiotherapy in standard treatment of advanced intrahepatic cholangiocarcinoma? 48
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 47
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 42
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 34
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 32
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand? 30
Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience 29
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 27
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 26
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 25
Hacking pancreatic cancer: Present and future of personalized medicine 24
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma 23
Hacking pancreatic cancer: Present and future of personalized medicine 21
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 20
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 19
Experimental HER2- targeted therapies for biliary tract cancer 19
The use of comprehensive complication Index® in pancreatic surgery: a comparison with the Clavien-Dindo system in a high volume center 18
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 15
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges 14
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 14
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma 13
Molecular features and targeted therapies in extrahepatic cholangiocarcinoma: Promises and failures 13
Nivolumab: an investigational agent for the treatment of biliary tract cancer 12
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 12
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 11
Totale 3043
Categoria #
all - tutte 4382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4382


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201864 0000 12 07 70452
2018/2019143 11772 219 914 1022832
2019/2020727 8625438 8374 9293 109583926
2020/2021605 8120137 528 6145 623437212
2021/20221083 68374375 7034 2678 137114241160
2022/2023400 128206660 00 00 0000
Totale 3043